1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Osteoarthritis Pain Solution Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Oral 1.2.3 Injection 1.2.4 External 1.3 Market Segment by Application 1.3.1 Global Osteoarthritis Pain Solution Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Osteoarthritis Pain Solution Market Size (2017-2028) 2.1.1 Global Osteoarthritis Pain Solution Revenue (2017-2028) 2.1.2 Global Osteoarthritis Pain Solution Sales (2017-2028) 2.2 Global Osteoarthritis Pain Solution Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Osteoarthritis Pain Solution Sales by Regions (2017-2022) 2.2.2 Global Osteoarthritis Pain Solution Revenue by Regions (2017-2022) 2.3 Global Osteoarthritis Pain Solution Market Size Forecast by Region 2.3.1 Global Osteoarthritis Pain Solution Sales Forecast by Region (2023-2028) 2.3.2 Global Osteoarthritis Pain Solution Revenue Forecast by Region (2023-2028) 2.4 Global Top Osteoarthritis Pain Solution Regions (Countries) Ranking by Market Size 2.5 Osteoarthritis Pain Solution Market Dynamics 2.5.1 Osteoarthritis Pain Solution Market Trends 2.5.2 Osteoarthritis Pain Solution Market Drivers 2.5.3 Osteoarthritis Pain Solution Market Challenges 2.5.4 Osteoarthritis Pain Solution Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Osteoarthritis Pain Solution Manufacturers by Sales (2017-2022) 3.1.1 Global Osteoarthritis Pain Solution Sales by Manufacturers (2017-2022) 3.1.2 Global Osteoarthritis Pain Solution Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Osteoarthritis Pain Solution Sales in 2021 3.2 Global Top Manufacturers Osteoarthritis Pain Solution by Revenue 3.2.1 Global Osteoarthritis Pain Solution Revenue by Manufacturers (2017-2022) 3.2.2 Top Osteoarthritis Pain Solution Manufacturers Covered: Ranking by Revenue 3.2.3 Global Osteoarthritis Pain Solution Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Osteoarthritis Pain Solution Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain Solution as of 2021) 3.4 Global Osteoarthritis Pain Solution Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Osteoarthritis Pain Solution Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Osteoarthritis Pain Solution Market 3.7 Key Manufacturers Osteoarthritis Pain Solution Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Osteoarthritis Pain Solution Market Size by Type 4.1 Global Osteoarthritis Pain Solution Historic Market Review by Type (2017-2022) 4.1.1 Global Osteoarthritis Pain Solution Sales Market Share by Type (2017-2022) 4.1.2 Global Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2022) 4.1.3 Osteoarthritis Pain Solution Price by Type (2017-2022) 4.2 Global Osteoarthritis Pain Solution Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Osteoarthritis Pain Solution Sales Forecast by Type (2023-2028) 4.2.2 Global Osteoarthritis Pain Solution Revenue Forecast by Type (2023-2028) 4.2.3 Osteoarthritis Pain Solution Price Forecast by Type (2023-2028) 5 Global Osteoarthritis Pain Solution Market Size by Application 5.1 Global Osteoarthritis Pain Solution Historic Market Review by Application (2017-2022) 5.1.1 Global Osteoarthritis Pain Solution Sales Market Share by Application (2017-2022) 5.1.2 Global Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2022) 5.1.3 Osteoarthritis Pain Solution Price by Application (2017-2022) 5.2 Global Osteoarthritis Pain Solution Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Osteoarthritis Pain Solution Sales Forecast by Application (2023-2028) 5.2.2 Global Osteoarthritis Pain Solution Revenue Forecast by Application (2023-2028) 5.2.3 Osteoarthritis Pain Solution Price Forecast by Application (2023-2028) 6 North America 6.1 North America Osteoarthritis Pain Solution Sales Breakdown by Company 6.1.1 North America Osteoarthritis Pain Solution Sales by Company (2017-2022) 6.1.2 North America Osteoarthritis Pain Solution Revenue by Company (2017-2022) 6.2 North America Osteoarthritis Pain Solution Market Size by Type 6.2.1 North America Osteoarthritis Pain Solution Sales by Type (2017-2028) 6.2.2 North America Osteoarthritis Pain Solution Revenue by Type (2017-2028) 6.3 North America Osteoarthritis Pain Solution Market Size by Application 6.3.1 North America Osteoarthritis Pain Solution Sales by Application (2017-2028) 6.3.2 North America Osteoarthritis Pain Solution Revenue by Application (2017-2028) 6.4 North America Osteoarthritis Pain Solution Market Size by Country 6.4.1 North America Osteoarthritis Pain Solution Sales by Country (2017-2028) 6.4.2 North America Osteoarthritis Pain Solution Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Osteoarthritis Pain Solution Sales Breakdown by Company 7.1.1 Europe Osteoarthritis Pain Solution Sales by Company (2017-2022) 7.1.2 Europe Osteoarthritis Pain Solution Revenue by Company (2017-2022) 7.2 Europe Osteoarthritis Pain Solution Market Size by Type 7.2.1 Europe Osteoarthritis Pain Solution Sales by Type (2017-2028) 7.2.2 Europe Osteoarthritis Pain Solution Revenue by Type (2017-2028) 7.3 Europe Osteoarthritis Pain Solution Market Size by Application 7.3.1 Europe Osteoarthritis Pain Solution Sales by Application (2017-2028) 7.3.2 Europe Osteoarthritis Pain Solution Revenue by Application (2017-2028) 7.4 Europe Osteoarthritis Pain Solution Market Size by Country 7.4.1 Europe Osteoarthritis Pain Solution Sales by Country (2017-2028) 7.4.2 Europe Osteoarthritis Pain Solution Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Osteoarthritis Pain Solution Sales Breakdown by Company 8.1.1 Asia Pacific Osteoarthritis Pain Solution Sales by Company (2017-2022) 8.1.2 Asia Pacific Osteoarthritis Pain Solution Revenue by Company (2017-2022) 8.2 Asia Pacific Osteoarthritis Pain Solution Market Size by Type 8.2.1 Asia Pacific Osteoarthritis Pain Solution Sales by Type (2017-2028) 8.2.2 Asia Pacific Osteoarthritis Pain Solution Revenue by Type (2017-2028) 8.3 Asia Pacific Osteoarthritis Pain Solution Market Size by Application 8.3.1 Asia Pacific Osteoarthritis Pain Solution Sales by Application (2017-2028) 8.3.2 Asia Pacific Osteoarthritis Pain Solution Revenue by Application (2017-2028) 8.4 Asia Pacific Osteoarthritis Pain Solution Market Size by Region 8.4.1 Asia Pacific Osteoarthritis Pain Solution Sales by Region 8.4.2 Asia Pacific Osteoarthritis Pain Solution Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Osteoarthritis Pain Solution Sales Breakdown by Company 9.1.1 Latin America Osteoarthritis Pain Solution Sales by Company (2017-2022) 9.1.2 Latin America Osteoarthritis Pain Solution Revenue by Company (2017-2022) 9.2 Latin America Osteoarthritis Pain Solution Market Size by Type 9.2.1 Latin America Osteoarthritis Pain Solution Sales by Type (2017-2028) 9.2.2 Latin America Osteoarthritis Pain Solution Revenue by Type (2017-2028) 9.3 Latin America Osteoarthritis Pain Solution Market Size by Application 9.3.1 Latin America Osteoarthritis Pain Solution Sales by Application (2017-2028) 9.3.2 Latin America Osteoarthritis Pain Solution Revenue by Application (2017-2028) 9.4 Latin America Osteoarthritis Pain Solution Market Size by Country 9.4.1 Latin America Osteoarthritis Pain Solution Sales by Country (2017-2028) 9.4.2 Latin America Osteoarthritis Pain Solution Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Osteoarthritis Pain Solution Sales Breakdown by Company 10.1.1 Middle East and Africa Osteoarthritis Pain Solution Sales by Company (2017-2022) 10.1.2 Middle East and Africa Osteoarthritis Pain Solution Revenue by Company (2017-2022) 10.2 Middle East and Africa Osteoarthritis Pain Solution Market Size by Type 10.2.1 Middle East and Africa Osteoarthritis Pain Solution Sales by Type (2017-2028) 10.2.2 Middle East and Africa Osteoarthritis Pain Solution Revenue by Type (2017-2028) 10.3 Middle East and Africa Osteoarthritis Pain Solution Market Size by Application 10.3.1 Middle East and Africa Osteoarthritis Pain Solution Sales by Application (2017-2028) 10.3.2 Middle East and Africa Osteoarthritis Pain Solution Revenue by Application (2017-2028) 10.4 Middle East and Africa Osteoarthritis Pain Solution Market Size by Country 10.4.1 Middle East and Africa Osteoarthritis Pain Solution Sales by Country (2017-2028) 10.4.2 Middle East and Africa Osteoarthritis Pain Solution Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Corporation Information 11.1.2 Pfizer Overview 11.1.3 Pfizer Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Pfizer Osteoarthritis Pain Solution Products and Services 11.1.5 Pfizer Osteoarthritis Pain Solution SWOT Analysis 11.1.6 Pfizer Recent Developments 11.2 Johnson and Johnson 11.2.1 Johnson and Johnson Corporation Information 11.2.2 Johnson and Johnson Overview 11.2.3 Johnson and Johnson Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Johnson and Johnson Osteoarthritis Pain Solution Products and Services 11.2.5 Johnson and Johnson Osteoarthritis Pain Solution SWOT Analysis 11.2.6 Johnson and Johnson Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Overview 11.3.3 GlaxoSmithKline Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 GlaxoSmithKline Osteoarthritis Pain Solution Products and Services 11.3.5 GlaxoSmithKline Osteoarthritis Pain Solution SWOT Analysis 11.3.6 GlaxoSmithKline Recent Developments 11.4 Bayer 11.4.1 Bayer Corporation Information 11.4.2 Bayer Overview 11.4.3 Bayer Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Bayer Osteoarthritis Pain Solution Products and Services 11.4.5 Bayer Osteoarthritis Pain Solution SWOT Analysis 11.4.6 Bayer Recent Developments 11.5 Eli Lilly 11.5.1 Eli Lilly Corporation Information 11.5.2 Eli Lilly Overview 11.5.3 Eli Lilly Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Eli Lilly Osteoarthritis Pain Solution Products and Services 11.5.5 Eli Lilly Osteoarthritis Pain Solution SWOT Analysis 11.5.6 Eli Lilly Recent Developments 11.6 Novartis 11.6.1 Novartis Corporation Information 11.6.2 Novartis Overview 11.6.3 Novartis Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Novartis Osteoarthritis Pain Solution Products and Services 11.6.5 Novartis Osteoarthritis Pain Solution SWOT Analysis 11.6.6 Novartis Recent Developments 11.7 Sanofi 11.7.1 Sanofi Corporation Information 11.7.2 Sanofi Overview 11.7.3 Sanofi Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Sanofi Osteoarthritis Pain Solution Products and Services 11.7.5 Sanofi Osteoarthritis Pain Solution SWOT Analysis 11.7.6 Sanofi Recent Developments 11.8 Horizon Pharma 11.8.1 Horizon Pharma Corporation Information 11.8.2 Horizon Pharma Overview 11.8.3 Horizon Pharma Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Horizon Pharma Osteoarthritis Pain Solution Products and Services 11.8.5 Horizon Pharma Osteoarthritis Pain Solution SWOT Analysis 11.8.6 Horizon Pharma Recent Developments 11.9 Abbott 11.9.1 Abbott Corporation Information 11.9.2 Abbott Overview 11.9.3 Abbott Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Abbott Osteoarthritis Pain Solution Products and Services 11.9.5 Abbott Osteoarthritis Pain Solution SWOT Analysis 11.9.6 Abbott Recent Developments 11.10 Mylan 11.10.1 Mylan Corporation Information 11.10.2 Mylan Overview 11.10.3 Mylan Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Mylan Osteoarthritis Pain Solution Products and Services 11.10.5 Mylan Osteoarthritis Pain Solution SWOT Analysis 11.10.6 Mylan Recent Developments 11.11 Daiichi Sankyo 11.11.1 Daiichi Sankyo Corporation Information 11.11.2 Daiichi Sankyo Overview 11.11.3 Daiichi Sankyo Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Daiichi Sankyo Osteoarthritis Pain Solution Products and Services 11.11.5 Daiichi Sankyo Recent Developments 11.12 TEVA 11.12.1 TEVA Corporation Information 11.12.2 TEVA Overview 11.12.3 TEVA Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 TEVA Osteoarthritis Pain Solution Products and Services 11.12.5 TEVA Recent Developments 11.13 Almatica Pharma 11.13.1 Almatica Pharma Corporation Information 11.13.2 Almatica Pharma Overview 11.13.3 Almatica Pharma Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Almatica Pharma Osteoarthritis Pain Solution Products and Services 11.13.5 Almatica Pharma Recent Developments 11.14 Astellas Pharma 11.14.1 Astellas Pharma Corporation Information 11.14.2 Astellas Pharma Overview 11.14.3 Astellas Pharma Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Astellas Pharma Osteoarthritis Pain Solution Products and Services 11.14.5 Astellas Pharma Recent Developments 11.15 Tide Pharmaceutical 11.15.1 Tide Pharmaceutical Corporation Information 11.15.2 Tide Pharmaceutical Overview 11.15.3 Tide Pharmaceutical Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 Tide Pharmaceutical Osteoarthritis Pain Solution Products and Services 11.15.5 Tide Pharmaceutical Recent Developments 11.16 Iroko Pharmaceuticals 11.16.1 Iroko Pharmaceuticals Corporation Information 11.16.2 Iroko Pharmaceuticals Overview 11.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.16.4 Iroko Pharmaceuticals Osteoarthritis Pain Solution Products and Services 11.16.5 Iroko Pharmaceuticals Recent Developments 11.17 Hengrui Pharmaceutical 11.17.1 Hengrui Pharmaceutical Corporation Information 11.17.2 Hengrui Pharmaceutical Overview 11.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.17.4 Hengrui Pharmaceutical Osteoarthritis Pain Solution Products and Services 11.17.5 Hengrui Pharmaceutical Recent Developments 11.18 Abiogen Pharma 11.18.1 Abiogen Pharma Corporation Information 11.18.2 Abiogen Pharma Overview 11.18.3 Abiogen Pharma Osteoarthritis Pain Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.18.4 Abiogen Pharma Osteoarthritis Pain Solution Products and Services 11.18.5 Abiogen Pharma Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Osteoarthritis Pain Solution Value Chain Analysis 12.2 Osteoarthritis Pain Solution Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Osteoarthritis Pain Solution Production Mode & Process 12.4 Osteoarthritis Pain Solution Sales and Marketing 12.4.1 Osteoarthritis Pain Solution Sales Channels 12.4.2 Osteoarthritis Pain Solution Distributors 12.5 Osteoarthritis Pain Solution Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Osteoarthritis Pain Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Oral Table 3. Major Manufacturers of Injection Table 4. Major Manufacturers of External Table 5. Global Osteoarthritis Pain Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Osteoarthritis Pain Solution Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 7. Global Osteoarthritis Pain Solution Sales by Region (2017-2022) & (K Units) Table 8. Global Osteoarthritis Pain Solution Sales Market Share by Region (2017-2022) Table 9. Global Osteoarthritis Pain Solution Revenue by Region (2017-2022) & (US$ Million) Table 10. Global Osteoarthritis Pain Solution Revenue Market Share by Region (2017-2022) Table 11. Global Osteoarthritis Pain Solution Sales Forecast by Region (2023-2028) & (K Units) Table 12. Global Osteoarthritis Pain Solution Sales Market Share Forecast by Region (2023-2028) Table 13. Global Osteoarthritis Pain Solution Revenue Forecast by Region (2023-2028) & (US$ Million) Table 14. Global Osteoarthritis Pain Solution Revenue Market Share Forecast by Region (2023-2028) Table 15. Top Osteoarthritis Pain Solution Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 16. Osteoarthritis Pain Solution Market Trends Table 17. Osteoarthritis Pain Solution Market Drivers Table 18. Osteoarthritis Pain Solution Market Challenges Table 19. Osteoarthritis Pain Solution Market Restraints Table 20. Global Osteoarthritis Pain Solution Sales by Manufacturers (2017-2022) & (K Units) Table 21. Global Osteoarthritis Pain Solution Sales Share by Manufacturers (2017-2022) Table 22. Global Osteoarthritis Pain Solution Revenue by Manufacturers (2017-2022) & (US$ Million) Table 23. Ranking of Global Top Osteoarthritis Pain Solution Manufacturers by Revenue (US$ Million) in 2021 Table 24. Osteoarthritis Pain Solution Revenue Share by Manufacturers (2017-2022) Table 25. Global Osteoarthritis Pain Solution Manufacturers Market Concentration Ratio (CR5 and HHI) Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain Solution as of 2021) Table 27. Key Manufacturers Osteoarthritis Pain Solution Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 28. Key Manufacturers Osteoarthritis Pain Solution Plants/Factories Distribution Table 29. Key Manufacturers Osteoarthritis Pain Solution Area Served Table 30. Date of Key Manufacturers Enter into Osteoarthritis Pain Solution Market Table 31. Key Manufacturers Osteoarthritis Pain Solution Product Type Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Osteoarthritis Pain Solution Sales (K Units) by Type (2017-2022) Table 34. Global Osteoarthritis Pain Solution Sales Share by Type (2017-2022) Table 35. Global Osteoarthritis Pain Solution Revenue (US$ Million) Market Share by Type (2017-2022) Table 36. Global Osteoarthritis Pain Solution Price (K Units) by Type (2017-2022) Table 37. Global Osteoarthritis Pain Solution Sales (K Units) by Type (2023-2028) Table 38. Global Osteoarthritis Pain Solution Sales Share by Type (2023-2028) Table 39. Global Osteoarthritis Pain Solution Revenue (US$ Million) Market Share by Type (2023-2028) Table 40. Global Osteoarthritis Pain Solution Revenue Share by Type (2023-2028) Table 41. Global Osteoarthritis Pain Solution Price (K Units) by Type (2023-2028) Table 42. Global Osteoarthritis Pain Solution Sales (K Units) by Application (2017-2022) Table 43. Global Osteoarthritis Pain Solution Sales Share by Application (2017-2022) Table 44. Global Osteoarthritis Pain Solution Revenue (US$ Million) Market Share by Application (2017-2022) Table 45. Global Osteoarthritis Pain Solution Price (K Units) by Application (2017-2022) Table 46. Global Osteoarthritis Pain Solution Sales (K Units) by Application (2023-2028) Table 47. Global Osteoarthritis Pain Solution Sales Share by Application (2023-2028) Table 48. Global Osteoarthritis Pain Solution Revenue (US$ Million) Market Share by Application (2023-2028) Table 49. Global Osteoarthritis Pain Solution Revenue Share by Application (2023-2028) Table 50. Global Osteoarthritis Pain Solution Price (K Units) by Application (2023-2028) Table 51. North America Osteoarthritis Pain Solution Sales by Company (2017-2022) & (K Units) Table 52. North America Osteoarthritis Pain Solution Sales Market Share by Company (2017-2022) Table 53. North America Osteoarthritis Pain Solution Revenue by Company (2017-2022) & (US$ Million) Table 54. North America Osteoarthritis Pain Solution Revenue Market Share by Company (2017-2022) Table 55. North America Osteoarthritis Pain Solution Sales by Type (2017-2022) & (K Units) Table 56. North America Osteoarthritis Pain Solution Sales by Type (2023-2028) & (K Units) Table 57. North America Osteoarthritis Pain Solution Revenue by Type (2017-2022) & (US$ Million) Table 58. North America Osteoarthritis Pain Solution Revenue by Type (2023-2028) & (US$ Million) Table 59. North America Osteoarthritis Pain Solution Sales by Application (2017-2022) & (K Units) Table 60. North America Osteoarthritis Pain Solution Sales by Application (2023-2028) & (K Units) Table 61. North America Osteoarthritis Pain Solution Revenue by Application (2017-2022) & (US$ Million) Table 62. North America Osteoarthritis Pain Solution Revenue by Application (2023-2028) & (US$ Million) Table 63. North America Osteoarthritis Pain Solution Sales by Country (2017-2022) & (K Units) Table 64. North America Osteoarthritis Pain Solution Sales by Country (2023-2028) & (K Units) Table 65. North America Osteoarthritis Pain Solution Revenue by Country (2017-2022) & (US$ Million) Table 66. North America Osteoarthritis Pain Solution Revenue by Country (2023-2028) & (US$ Million) Table 67. Europe Osteoarthritis Pain Solution Sales by Company (2017-2022) & (K Units) Table 68. Europe Osteoarthritis Pain Solution Sales Market Share by Company (2017-2022) Table 69. Europe Osteoarthritis Pain Solution Revenue by Company (2017-2022) & (US$ Million) Table 70. Europe Osteoarthritis Pain Solution Revenue Market Share by Company (2017-2022) Table 71. Europe Osteoarthritis Pain Solution Sales by Type (2017-2022) & (K Units) Table 72. Europe Osteoarthritis Pain Solution Sales by Type (2023-2028) & (K Units) Table 73. Europe Osteoarthritis Pain Solution Revenue by Type (2017-2022) & (US$ Million) Table 74. Europe Osteoarthritis Pain Solution Revenue by Type (2023-2028) & (US$ Million) Table 75. Europe Osteoarthritis Pain Solution Sales by Application (2017-2022) & (K Units) Table 76. Europe Osteoarthritis Pain Solution Sales by Application (2023-2028) & (K Units) Table 77. Europe Osteoarthritis Pain Solution Revenue by Application (2017-2022) & (US$ Million) Table 78. Europe Osteoarthritis Pain Solution Revenue by Application (2023-2028) & (US$ Million) Table 79. Europe Osteoarthritis Pain Solution Sales by Country (2017-2022) & (K Units) Table 80. Europe Osteoarthritis Pain Solution Sales by Country (2023-2028) & (K Units) Table 81. Europe Osteoarthritis Pain Solution Revenue by Country (2017-2022) & (US$ Million) Table 82. Europe Osteoarthritis Pain Solution Revenue by Country (2023-2028) & (US$ Million) Table 83. Asia Pacific Osteoarthritis Pain Solution Sales by Company (2017-2022) & (K Units) Table 84. Asia Pacific Osteoarthritis Pain Solution Sales Market Share by Company (2017-2022) Table 85. Asia Pacific Osteoarthritis Pain Solution Revenue by Company (2017-2022) & (US$ Million) Table 86. Asia Pacific Osteoarthritis Pain Solution Revenue Market Share by Company (2017-2022) Table 87. Asia Pacific Osteoarthritis Pain Solution Sales by Type (2017-2022) & (K Units) Table 88. Asia Pacific Osteoarthritis Pain Solution Sales by Type (2023-2028) & (K Units) Table 89. Asia Pacific Osteoarthritis Pain Solution Revenue by Type (2017-2022) & (US$ Million) Table 90. Asia Pacific Osteoarthritis Pain Solution Revenue by Type (2023-2028) & (US$ Million) Table 91. Asia Pacific Osteoarthritis Pain Solution Sales by Application (2017-2022) & (K Units) Table 92. Asia Pacific Osteoarthritis Pain Solution Sales by Application (2023-2028) & (K Units) Table 93. Asia Pacific Osteoarthritis Pain Solution Revenue by Application (2017-2022) & (US$ Million) Table 94. Asia Pacific Osteoarthritis Pain Solution Revenue by Application (2023-2028) & (US$ Million) Table 95. Asia Pacific Osteoarthritis Pain Solution Sales by Region (2017-2022) & (K Units) Table 96. Asia Pacific Osteoarthritis Pain Solution Sales by Region (2023-2028) & (K Units) Table 97. Asia Pacific Osteoarthritis Pain Solution Revenue by Region (2017-2022) & (US$ Million) Table 98. Asia Pacific Osteoarthritis Pain Solution Revenue by Region (2023-2028) & (US$ Million) Table 99. Latin America Osteoarthritis Pain Solution Sales by Company (2017-2022) & (K Units) Table 100. Latin America Osteoarthritis Pain Solution Sales Market Share by Company (2017-2022) Table 101. Latin America Osteoarthritis Pain Solution Revenue by Company (2017-2022) & (US$ Million) Table 102. Latin America Osteoarthritis Pain Solution Revenue Market Share by Company (2017-2022) Table 103. Latin America Osteoarthritis Pain Solution Sales by Type (2017-2022) & (K Units) Table 104. Latin America Osteoarthritis Pain Solution Sales by Type (2023-2028) & (K Units) Table 105. Latin America Osteoarthritis Pain Solution Revenue by Type (2017-2022) & (US$ Million) Table 106. Latin America Osteoarthritis Pain Solution Revenue by Type (2023-2028) & (US$ Million) Table 107. Latin America Osteoarthritis Pain Solution Sales by Application (2017-2022) & (K Units) Table 108. Latin America Osteoarthritis Pain Solution Sales by Application (2023-2028) & (K Units) Table 109. Latin America Osteoarthritis Pain Solution Revenue by Application (2017-2022) & (US$ Million) Table 110. Latin America Osteoarthritis Pain Solution Revenue by Application (2023-2028) & (US$ Million) Table 111. Latin America Osteoarthritis Pain Solution Sales by Country (2017-2022) & (K Units) Table 112. Latin America Osteoarthritis Pain Solution Sales by Country (2023-2028) & (K Units) Table 113. Latin America Osteoarthritis Pain Solution Revenue by Country (2017-2022) & (US$ Million) Table 114. Latin America Osteoarthritis Pain Solution Revenue by Country (2023-2028) & (US$ Million) Table 115. Middle East and Africa Osteoarthritis Pain Solution Sales by Company (2017-2022) & (K Units) Table 116. Middle East and Africa Osteoarthritis Pain Solution Sales Market Share by Company (2017-2022) Table 117. Middle East and Africa Osteoarthritis Pain Solution Revenue by Company (2017-2022) & (US$ Million) Table 118. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Company (2017-2022) Table 119. Middle East and Africa Osteoarthritis Pain Solution Sales by Type (2017-2022) & (K Units) Table 120. Middle East and Africa Osteoarthritis Pain Solution Sales by Type (2023-2028) & (K Units) Table 121. Middle East and Africa Osteoarthritis Pain Solution Revenue by Type (2017-2022) & (US$ Million) Table 122. Middle East and Africa Osteoarthritis Pain Solution Revenue by Type (2023-2028) & (US$ Million) Table 123. Middle East and Africa Osteoarthritis Pain Solution Sales by Application (2017-2022) & (K Units) Table 124. Middle East and Africa Osteoarthritis Pain Solution Sales by Application (2023-2028) & (K Units) Table 125. Middle East and Africa Osteoarthritis Pain Solution Revenue by Application (2017-2022) & (US$ Million) Table 126. Middle East and Africa Osteoarthritis Pain Solution Revenue by Application (2023-2028) & (US$ Million) Table 127. Middle East and Africa Osteoarthritis Pain Solution Sales by Country (2017-2022) & (K Units) Table 128. Middle East and Africa Osteoarthritis Pain Solution Sales by Country (2023-2028) & (K Units) Table 129. Middle East and Africa Osteoarthritis Pain Solution Revenue by Country (2017-2022) & (US$ Million) Table 130. Middle East and Africa Osteoarthritis Pain Solution Revenue by Country (2023-2028) & (US$ Million) Table 131. Pfizer Corporation Information Table 132. Pfizer Description and Overview Table 133. Pfizer Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 134. Pfizer Osteoarthritis Pain Solution Product and Services Table 135. Pfizer Osteoarthritis Pain Solution SWOT Analysis Table 136. Pfizer Recent Developments Table 137. Johnson and Johnson Corporation Information Table 138. Johnson and Johnson Description and Overview Table 139. Johnson and Johnson Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 140. Johnson and Johnson Osteoarthritis Pain Solution Product and Services Table 141. Johnson and Johnson Osteoarthritis Pain Solution SWOT Analysis Table 142. Johnson and Johnson Recent Developments Table 143. GlaxoSmithKline Corporation Information Table 144. GlaxoSmithKline Description and Overview Table 145. GlaxoSmithKline Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 146. GlaxoSmithKline Osteoarthritis Pain Solution Product and Services Table 147. GlaxoSmithKline Osteoarthritis Pain Solution SWOT Analysis Table 148. GlaxoSmithKline Recent Developments Table 149. Bayer Corporation Information Table 150. Bayer Description and Overview Table 151. Bayer Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 152. Bayer Osteoarthritis Pain Solution Product and Services Table 153. Bayer Osteoarthritis Pain Solution SWOT Analysis Table 154. Bayer Recent Developments Table 155. Eli Lilly Corporation Information Table 156. Eli Lilly Description and Overview Table 157. Eli Lilly Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 158. Eli Lilly Osteoarthritis Pain Solution Product and Services Table 159. Eli Lilly Osteoarthritis Pain Solution SWOT Analysis Table 160. Eli Lilly Recent Developments Table 161. Novartis Corporation Information Table 162. Novartis Description and Overview Table 163. Novartis Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 164. Novartis Osteoarthritis Pain Solution Product and Services Table 165. Novartis Osteoarthritis Pain Solution SWOT Analysis Table 166. Novartis Recent Developments Table 167. Sanofi Corporation Information Table 168. Sanofi Description and Overview Table 169. Sanofi Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 170. Sanofi Osteoarthritis Pain Solution Product and Services Table 171. Sanofi Osteoarthritis Pain Solution SWOT Analysis Table 172. Sanofi Recent Developments Table 173. Horizon Pharma Corporation Information Table 174. Horizon Pharma Description and Overview Table 175. Horizon Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 176. Horizon Pharma Osteoarthritis Pain Solution Product and Services Table 177. Horizon Pharma Osteoarthritis Pain Solution SWOT Analysis Table 178. Horizon Pharma Recent Developments Table 179. Abbott Corporation Information Table 180. Abbott Description and Overview Table 181. Abbott Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 182. Abbott Osteoarthritis Pain Solution Product and Services Table 183. Abbott Osteoarthritis Pain Solution SWOT Analysis Table 184. Abbott Recent Developments Table 185. Mylan Corporation Information Table 186. Mylan Description and Overview Table 187. Mylan Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 188. Mylan Osteoarthritis Pain Solution Product and Services Table 189. Mylan Osteoarthritis Pain Solution SWOT Analysis Table 190. Mylan Recent Developments Table 191. Daiichi Sankyo Corporation Information Table 192. Daiichi Sankyo Description and Overview Table 193. Daiichi Sankyo Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 194. Daiichi Sankyo Osteoarthritis Pain Solution Product and Services Table 195. Daiichi Sankyo Recent Developments Table 196. TEVA Corporation Information Table 197. TEVA Description and Overview Table 198. TEVA Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 199. TEVA Osteoarthritis Pain Solution Product and Services Table 200. TEVA Recent Developments Table 201. Almatica Pharma Corporation Information Table 202. Almatica Pharma Description and Overview Table 203. Almatica Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 204. Almatica Pharma Osteoarthritis Pain Solution Product and Services Table 205. Almatica Pharma Recent Developments Table 206. Astellas Pharma Corporation Information Table 207. Astellas Pharma Description and Overview Table 208. Astellas Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 209. Astellas Pharma Osteoarthritis Pain Solution Product and Services Table 210. Astellas Pharma Recent Developments Table 211. Tide Pharmaceutical Corporation Information Table 212. Tide Pharmaceutical Description and Overview Table 213. Tide Pharmaceutical Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 214. Tide Pharmaceutical Osteoarthritis Pain Solution Product and Services Table 215. Tide Pharmaceutical Recent Developments Table 216. Iroko Pharmaceuticals Corporation Information Table 217. Iroko Pharmaceuticals Description and Overview Table 218. Iroko Pharmaceuticals Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 219. Iroko Pharmaceuticals Osteoarthritis Pain Solution Product and Services Table 220. Iroko Pharmaceuticals Recent Developments Table 221. Hengrui Pharmaceutical Corporation Information Table 222. Hengrui Pharmaceutical Description and Overview Table 223. Hengrui Pharmaceutical Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 224. Hengrui Pharmaceutical Osteoarthritis Pain Solution Product and Services Table 225. Hengrui Pharmaceutical Recent Developments Table 226. Abiogen Pharma Corporation Information Table 227. Abiogen Pharma Description and Overview Table 228. Abiogen Pharma Osteoarthritis Pain Solution Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 229. Abiogen Pharma Osteoarthritis Pain Solution Product and Services Table 230. Abiogen Pharma Recent Developments Table 231. Key Raw Materials Lists Table 232. Raw Materials Key Suppliers Lists Table 233. Osteoarthritis Pain Solution Distributors List Table 234. Osteoarthritis Pain Solution Customers List Table 235. Research Programs/Design for This Report Table 236. Key Data Information from Secondary Sources Table 237. Key Data Information from Primary Sources List of Figures Figure 1. Osteoarthritis Pain Solution Product Picture Figure 2. Global Osteoarthritis Pain Solution Sales Market Share by Type in 2021 & 2028 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. External Product Picture Figure 6. Global Osteoarthritis Pain Solution Sales Market Share by Application in 2021 & 2028 Figure 7. Medical Care Use Case Figure 8. Personal Care Use Case Figure 9. Osteoarthritis Pain Solution Report Years Considered Figure 10. Global Osteoarthritis Pain Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Osteoarthritis Pain Solution Market Size 2017-2028 (US$ Million) Figure 12. Global Osteoarthritis Pain Solution Sales (2017-2022) & (K Units) Figure 13. Global Osteoarthritis Pain Solution Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Osteoarthritis Pain Solution Sales Market Share by Region (2017-2022) Figure 15. Global Osteoarthritis Pain Solution Sales Market Share by Region in 2021 Figure 16. Global Osteoarthritis Pain Solution Revenue Market Share by Region in 2017 VS 2021 Figure 17. Global Osteoarthritis Pain Solution Sales Share by Manufacturers in 2021 Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Osteoarthritis Pain Solution Sales in 2021 Figure 19. Osteoarthritis Pain Solution Revenue Share by Manufacturers in 2021 Figure 20. Osteoarthritis Pain Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Osteoarthritis Pain Solution Revenue Share by Type (2017-2022) Figure 22. Global Osteoarthritis Pain Solution Revenue Growth Rate by Type in 2017 & 2021 Figure 23. Global Osteoarthritis Pain Solution Revenue Share by Application (2017-2022) Figure 24. Global Osteoarthritis Pain Solution Revenue Growth Rate by Application in 2017 & 2021 Figure 25. North America Osteoarthritis Pain Solution Sales Market Share by Type (2017-2028) Figure 26. North America Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2028) Figure 27. North America Osteoarthritis Pain Solution Sales Market Share by Application (2017-2028) Figure 28. North America Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2028) Figure 29. North America Osteoarthritis Pain Solution Sales Share by Country (2017-2028) Figure 30. North America Osteoarthritis Pain Solution Revenue Share by Country (2017-2028) Figure 31. U.S. Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 32. Canada Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 33. Europe Osteoarthritis Pain Solution Sales Market Share by Type (2017-2028) Figure 34. Europe Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2028) Figure 35. Europe Osteoarthritis Pain Solution Sales Market Share by Application (2017-2028) Figure 36. Europe Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2028) Figure 37. Europe Osteoarthritis Pain Solution Sales Share by Country (2017-2028) Figure 38. Europe Osteoarthritis Pain Solution Revenue Share by Country (2017-2028) Figure 39. Germany Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 40. France Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 41. U.K. Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 42. Italy Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 43. Russia Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 44. Asia Pacific Osteoarthritis Pain Solution Sales Market Share by Type (2017-2028) Figure 45. Asia Pacific Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2028) Figure 46. Asia Pacific Osteoarthritis Pain Solution Sales Market Share by Application (2017-2028) Figure 47. Asia Pacific Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2028) Figure 48. Asia Pacific Osteoarthritis Pain Solution Sales Share by Region (2017-2028) Figure 49. Asia Pacific Osteoarthritis Pain Solution Revenue Share by Region (2017-2028) Figure 50. China Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 51. Japan Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 52. South Korea Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 53. India Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 54. Australia Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 55. Taiwan Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 56. Indonesia Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 57. Thailand Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 58. Malaysia Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 59. Philippines Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 60. Vietnam Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 61. Latin America Osteoarthritis Pain Solution Sales Market Share by Type (2017-2028) Figure 62. Latin America Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2028) Figure 63. Latin America Osteoarthritis Pain Solution Sales Market Share by Application (2017-2028) Figure 64. Latin America Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2028) Figure 65. Latin America Osteoarthritis Pain Solution Sales Share by Country (2017-2028) Figure 66. Latin America Osteoarthritis Pain Solution Revenue Share by Country (2017-2028) Figure 67. Mexico Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 68. Brazil Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 69. Argentina Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 70. Middle East and Africa Osteoarthritis Pain Solution Sales Market Share by Type (2017-2028) Figure 71. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Type (2017-2028) Figure 72. Middle East and Africa Osteoarthritis Pain Solution Sales Market Share by Application (2017-2028) Figure 73. Middle East and Africa Osteoarthritis Pain Solution Revenue Market Share by Application (2017-2028) Figure 74. Middle East and Africa Osteoarthritis Pain Solution Sales Share by Country (2017-2028) Figure 75. Middle East and Africa Osteoarthritis Pain Solution Revenue Share by Country (2017-2028) Figure 76. Turkey Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 77. Saudi Arabia Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 78. UAE Osteoarthritis Pain Solution Revenue (2017-2028) & (US$ Million) Figure 79. Osteoarthritis Pain Solution Value Chain Figure 80. Osteoarthritis Pain Solution Production Process Figure 81. Channels of Distribution Figure 82. Distributors Profiles Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma